Commercial Advisor
Former VP, R&D Asia, and Sr. Research Fellow, Eli Lilly ($106B Market Cap)
CEO， Tyligand Bioscience. Chairman of the BoD of BayHelix Group. 25 years’ experience in new drug discovery and development.